Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Amgen Inc (AMGN)

Amgen Inc (AMGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 126,757,368
  • Shares Outstanding, K 563,266
  • Annual Sales, $ 25,424 M
  • Annual Income, $ 7,264 M
  • 60-Month Beta 0.64
  • Price/Sales 5.05
  • Price/Cash Flow 9.83
  • Price/Book 15.50
Trade AMGN with:

Options Overview Details

View History
  • Implied Volatility 27.55% ( -1.00%)
  • Historical Volatility 14.85%
  • IV Percentile 93%
  • IV Rank 51.28%
  • IV High 37.35% on 01/28/21
  • IV Low 17.25% on 06/17/21
  • Put/Call Vol Ratio 0.75
  • Today's Volume 1,489
  • Volume Avg (30-Day) 6,261
  • Put/Call OI Ratio 0.40
  • Today's Open Interest 47,878
  • Open Int (30-Day) 81,003

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/21
See More
  • Average Estimate 4.11
  • Number of Estimates 9
  • High Estimate 4.25
  • Low Estimate 3.91
  • Prior Year 3.81
  • Growth Rate Est. (year over year) +7.87%

Price Performance

See More
Period Period Low Period High Performance
1-Month
219.98 +2.62%
on 01/24/22
235.80 -4.26%
on 01/14/22
+1.96 (+0.88%)
since 12/23/21
3-Month
198.64 +13.65%
on 12/01/21
235.80 -4.26%
on 01/14/22
+17.07 (+8.18%)
since 10/26/21
52-Week
198.64 +13.65%
on 12/01/21
276.69 -18.41%
on 01/28/21
-32.85 (-12.70%)
since 01/26/21

Most Recent Stories

More News
Amgen (AMGN) to Report Q4 Results: Wall Street Expects Earnings Growth

Amgen (AMGN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AMGN : 224.78 (-0.12%)
Amgen (AMGN) Stock Moves -0.52%: What You Should Know

Amgen (AMGN) closed the most recent trading day at $227.72, moving -0.52% from the previous trading session.

AMGN : 224.78 (-0.12%)
3 Healthcare Stocks With High Dividends

Looking for a healthcare stock that will pay you to own it? Here are three suggestions.

AMGN : 224.78 (-0.12%)
TAK : 14.48 (-0.28%)
PETS : 26.03 (+1.13%)
Amgen's (AMGN) KRAS Inhibitor Gets Nod in Japan for Lung Cancer

Amgen's (AMGN) KRAS inhibitor, Lumakras, gets approval in Japan for the treatment of KRAS G12C-mutated positive advanced/recurrent non-small-cell lung cancer.

DVAX : 13.11 (+4.05%)
AMGN : 224.78 (-0.12%)
MRTX : 117.69 (+3.20%)
ANAB : 33.81 (+4.03%)
J&J (JNJ) to Set the Stage for Pharma Sector Q4 Earnings

J&J's (JNJ) Pharma segment is expected to have performed above the market. It remains to be seen if sales improved in the Medical Devices segment in the fourth quarter.

GSK : 44.44 (+0.16%)
JNJ : 168.57 (+0.56%)
AMGN : 224.78 (-0.12%)
ABBV : 134.90 (+1.36%)
Amgen (AMGN) Stock Moves -1.04%: What You Should Know

Amgen (AMGN) closed at $228.90 in the latest trading session, marking a -1.04% move from the prior day.

AMGN : 224.78 (-0.12%)
$300 a Month in These 3 Stocks Could Make You a Millionaire by Retirement

These three stocks have proven to be wonderful compounders, and there's little reason to believe that will change anytime soon.

AFL : 62.47 (+0.92%)
GD : 207.03 (+0.52%)
AMGN : 224.78 (-0.12%)
CytomX (CTMX) Gets FDA Nod to Begin Study in Solid Tumors

The FDA clears CytomX's (CTMX) investigational new drug application for CX-904, which is being developed for the treatment of advanced solid tumors.

AMGN : 224.78 (-0.12%)
CARA : 11.83 (+0.34%)
CTMX : 4.51 (+3.20%)
ANAB : 33.81 (+4.03%)
Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know

Amgen (AMGN) closed at $235.36 in the latest trading session, marking a +1.95% move from the prior day.

AMGN : 224.78 (-0.12%)
BridgeBio (BBIO), Amgen Partner in Advanced Solid Tumors Study

BridgeBio (BBIO) forges an alliance with Amgen to evaluate their respective cancer drugs for the treatment of advanced solid tumors with KRAS G12C mutations.

SNY : 51.68 (+0.54%)
AMGN : 224.78 (-0.12%)
MRTX : 117.69 (+3.20%)
BBIO : 10.48 (+2.24%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Amgen Inc. discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice...

See More

Key Turning Points

3rd Resistance Point 232.83
2nd Resistance Point 230.17
1st Resistance Point 227.60
Last Price 224.78
1st Support Level 222.37
2nd Support Level 219.71
3rd Support Level 217.14

See More

52-Week High 276.69
Fibonacci 61.8% 246.87
Fibonacci 50% 237.67
Fibonacci 38.2% 228.46
Last Price 224.78
52-Week Low 198.64

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar